https://scholars.lib.ntu.edu.tw/handle/123456789/586551
標題: | Adjuvant intravitreal bevacizumab injection for choroidal and orbital metastases of refractory invasive ductal carcinoma of the breast | 作者: | Lin I.-H. BO-I KUO Liu F.-Y. |
關鍵字: | Bevacizumab; Breast cancer; Choroidal metastasis; Intravitreal injection; Orbital metastasis | 公開日期: | 2021 | 出版社: | MDPI AG | 卷: | 57 | 期: | 5 | 來源出版物: | Medicina (Lithuania) | 摘要: | The efficacy of combined intravitreal bevacizumab injection with systemic chemotherapy, palliative radiotherapy, and hormonal therapy to treat choroidal and orbital metastases is not known. Herein, we report the case of a 48-year-old woman with systemic chemotherapy-resistant choroidal and orbital metastases of the left eye originating from a stage IV invasive ductal carcinoma of the left breast. We describe the addition of a single intravitreal injection of bevacizumab in addition to treatment with systemic chemotherapy, hormonal therapy, and palliative radiotherapy. The patient’s outcome at 6-month follow-up was favorable, as the metastatic lesion reduced in size and visual acuity improved. Combined treatment with intravitreal bevacizumab injection, systemic chemotherapy, palliative radiotherapy, and hormonal therapy can resolve ocular metastatic lesions originating from breast cancers. ? 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105235757&doi=10.3390%2fmedicina57050404&partnerID=40&md5=12a73d73e5bb9e4d7d728a17b0b9d058 https://scholars.lib.ntu.edu.tw/handle/123456789/586551 |
ISSN: | 1010-660X | DOI: | 10.3390/medicina57050404 | SDG/關鍵字: | angiogenesis inhibitor; bevacizumab; case report; female; human; intravitreal drug administration; middle aged; optical coherence tomography; Paget nipple disease; Angiogenesis Inhibitors; Bevacizumab; Carcinoma, Ductal; Female; Humans; Intravitreal Injections; Middle Aged; Tomography, Optical Coherence |
顯示於: | 醫學院附設癌醫中心醫院(臺大癌醫) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。